Skip to main content

Spero Therapeutics, Inc. (NASDAQ: SPRO) Investor Securities Class Action Lawsuit 05/26/2022

  • If you purchased a significant amount of shares of Spero Therapeutics, Inc. (NASDAQ: SPRO) between October 28, 2021 and May 2, 2022, and / or if you purchased any NASDAQ: SPRO shares prior to October 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: July 25, 2022. NASDAQ: SPRO investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

December5, 2022 - An amended complaint was filed. May 26, 2022 - An investor in shares of Spero Therapeutics, Inc. (NASDAQ: SPRO) filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Spero Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between October 28, 2021...

You must register (for free) or login to view the entire case.